Cystic and Inherited Kidney Diseases

American Journal of Kidney Diseases

Volumn 42, Issue 6, 2003, Pages 1305-1317

  Rizk, Dana ^a   Chapman, Arlene B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALACTOSE;

ALPORT SYNDROME; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; DIALYSIS; ENZYME REPLACEMENT; FABRY DISEASE; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MEDULLARY SPONGE KIDNEY; NEPHROTIC SYNDROME; PATHOGENESIS; REVIEW; SODIUM RESTRICTION; THIN BASEMENT MEMBRANE DISEASE; TUBEROUS SCLEROSIS;

EID: 0345258070     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.10.002     Document Type: Article

References (58)

1. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329:332-342, 1993
2. Perrone RD: Extrarenal manifestations of ADPKD. Kidney Int 51:2022-2036, 1997
3. Peters DJM, Breuning MH: Autosomal dominant polycystic kidney disease: Modification of disease progression. Lancet 358:1439-1444, 2001
4. Ong ACM, Wheatley DN: Polycystic kidney disease-the ciliary connection. Lancet 361:774-776, 2003
5. Harris PC: Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1. Curr Opin Nephrol Hypertens 11:309-314, 2002
6. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in autosomal dominant polycystic kidney disease type I. Cell 87:979-987, 1996
7. Gardner KD Jr, Glew RH, Evan AP, McAteer JA, Bernstein J: Why renal cysts grow. Am J Physiol 266:353-359, 1994
8. Grantham JJ: The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances. Am J Kidney Dis 28:788-803, 1996
9. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343:824-827, 1994
10. Nascimento AB, Mitchell DG, Zhang X-M, Kamishima T, Parker L, Holland GA: Rapid MR imaging detection of renal cysts: Age-based standards. Radiology 221:628-632, 2001
11. Rosetti S, Strmecki L, Gamble V, et al: Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications. Am J Hum Genet 68:355-363, 2001
12. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1349-1354, 1994
13. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 289:2560-2572, 2003
14. Ecder T, Edelstein CL, Fick-Brosnahan GM, et al: Diuretics versus angiotensin converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol 21:98-103, 2001
15. Chapman AB, Johnson AM, Rainguet S, Hossak K, Gabow PA, Schrier RW: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8:1292-1297, 1997
16. Ecder T, Edelstein CL, Chapman AB, et al: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 14:1113-1116, 1999
17. Ecder T, Schrier RW: Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. J Am Soc Nephrol 12:194-200, 2001
18. Bennett WM, Elzinga LW: Clinical management of autosomal dominant polycystic kidney disease. Kidney Int suppl 42:S74-S79, 1993
19. Gabow PA, Bennett WM: Renal manifestations: Complication management and long-term outcome of autosomal dominant polycystic kidney disease. Semin Nephrol 11:643-652, 1991
20. Reynolds DM, Falk CT, Li A, et al: Identification of a locus for autosomal dominant polycystic liver disease on chromosome 19 p 13.2-13.1. Am J Hum Genet 67:1598-1604, 2000
21. Chapman AB, Rubinstein D, Hughes R, et al: Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 327:916-920, 1992
22. Sharp CK, Zeligman BE, Johnson AM, Duley IT, Gabow PA: Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease. Am J Kidney Dis 34:863-868, 1999
23. Morris-Stiff G, Coles G, Moore R, Jurewicz A, Lord R: Abdominal wall hernia in autosomal dominant polycystic kidney disease. Br J Surg 84:615-617, 1997
24. O'Callaghan FJ, Osborne JP: Advances in the understanding of tuberous sclerosis. Arch Dis Child 83:140-142, 2000
25. Fick GM, Johnson AM, Strain JD, et al: Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1863-1870, 1993
26. Chapman AB, Johnson AM, Gabow PA: Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1178-1185, 1994
27. Fonck C, Chauveau D, Gagnadoux M-F, Pirson Y, Grunfeld J-P: Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant 16:1648-1652, 2001
28. Ward CJ, Hogan MC, Rosetti S, et al: The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30:259-269, 2002
29. Bergmann C, Senderek J, Sedlacek B, et al: Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol 14:76-89, 2003
30. Igarashi P, Somlo S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13:2384-2398, 2002
31. Shaikewitz ST, Chapman AB: Autosomal recessive polycystic kidney disease: Issues regarding the variability of clinical presentation. J Am Soc Nephrol 3:1858-1862, 1993
32. Kaplan BS, Kaplan P, Rosenberg HK, Lamothe E, Rosenblatt DS: Polycystic kidney diseases in childhood. J Pediatr 115:867-880, 1989
33. Pirson Y: Making the diagnosis of Alport's syndrome. Kidney Int 56:760-775, 1999
34. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556, 2003
35. Kashtan CE: Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 9:1736-1750, 1998
36. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M: Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: Impact on clinical counselling. Nephrol Dial Transplant 17:1218-1227, 2002
37. Kashtan CE: Familial Henaturic syndromes-Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes. Contrib Nephrol 136:79-99, 2001
38. Cohen EP, Lemann J Jr: In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression. Am J Kidney Dis 27:199-203, 1996
39. Callis L, Vila A, Carrera M, Nieto J: Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int 55:1051-1056, 1999
40. Kalluri R, Torre A, Shield CF III, et al: Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 69:679-684, 2000
41. Ueda T, Nakajima M, Akazawa H, et al: Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease. Nephron 92:271-278, 2002
42. Ghiggeri GM, Caridi G, Magrini U, et al: Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 41:95-104, 2003
43. Hyman MH, Whittemore VH: National Institute of Health consensus conference: Tuberous sclerosis complex. Arch Neurol 57:662-665, 2000
44. Sparagana SP, Roach ES: Tuberous sclerosis complex. Curr Opin Neurol 13:115-119, 2000
45. Pastores GM, Lien YHH: Biochemical and molecular genetic basis of Fabry disease. J Am Soc Nephrol 13:S130-S133, 2002 (suppl 2)
46. Branton M, Schiffmann R, Kopp JB: Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13:S139-S143, 2002 (suppl 2)
47. Alroy J, Sabnis S, Kopp JB: Renal pathology in Fabry disease. J Am Soc Nephrol 13:S134-S138, 2002 (suppl 2)
48. Eng CM, Guffon N, Wilcox WR, et al: Safety and efficacy of recombinant human (alpha)-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 345:9-16, 2001
49. Obrador GT, Ojo A, Thadhani R: End-stage renal disease in patients with Fabry disease. J Am Soc Nephrol 13:S144-S146, 2002 (suppl 2)
50. Kampmann C, Baehner F, Ries M, Beck M: Cardiac involvement in Anderson-Fabry disease. J Am Soc Nephrol 13:S147-S149, 2002 (suppl 2)
51. Kolodny EH, Pastores GM: Anderson-Fabry disease: Extrarenal, neurologic manifestations. J Am Soc Nephrol 13:S150-S153, 2002 (suppl 2)
52. Scolari F, Viola BF, Prati E, et al: Medullary cystic kidney disease: Past and present. Contrib Nephrol 136:68-78, 2001
53. Fuchshuber A, Deltas CC, Berthold S, et al: Autosomal dominant medullary cystic kidney disease: Evidence of gene locus heterogeneity. Nephrol Dial Transplant 13:1955-1957, 1998
54. Scolari F, Puzzer D, Amoroso A, et al: Identification of a new locus for medullary cystic disease on chromosome 16p12. Am J Hum Genet 64:1655-1660, 1999
55. Hildebrandt F, Otto E: Molecular genetics of nephronophthisis and medullary cystic kidney disease. J Am Soc Nephrol 11:1753-1761, 2000
56. Neumann HP, Zauner I, Strahm B, et al: Late occurrence of cysts in autosomal dominant medullary cystic kidney disease. Nephrol Dial Transplant 12:1242-1246, 1997
57. Scolari F, Ghiggeri GM, Casari G, et al: Autosomal dominant medullary cystic disease: A disorder with variable clinical pictures and exclusion of linkage with the NPH1 locus. Nephrol Dial Transplant 13:2536-2546, 1998
58. Dahan K, Fuchshuber A, Adamis S, et al: Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: Two facets of the same disease? J Am Soc Nephrol 12:2348-2357, 2001